PMID: 8597613Feb 1, 1996Paper

Recent-onset myelodysplastic syndrome mimicking acute leukemia during infection

Annals of Hematology
H D Friedman, S A Landaw

Abstract

A previously healthy 74-year-old patient without a prior history of hematological disease presented with an acute respiratory infection. Peripheral pancytopenia led us to perform a bone marrow biopsy, and the diagnosis of undifferentiated acute myelogenous leukemia (AML, 61% blasts) was made. Following antibiotic treatment and resolution of the infection, the blast count in the bone marrow fell to 2%, leaving a clinicopathologic picture consistent with myelodysplastic syndrome (MDS, French-American-British type refractory anemia), and the patient survived for a total of 16.5 months following the initial presentation with cytokine support. A preterminal blast proliferation occurred during a bacterial ear infection and rapidly responded to a withdrawal of cytokine support, antibiotic therapy, and hydroxyurea. The patient succumbed ultimately to an apparent myocardial infarct. Clinicians should consider transient acceleration of MDS in their differential diagnosis when confronted with apparent AML and acute infection.

References

Oct 1, 1979·The American Journal of Medicine·N A LachantA J Gottlieb
Jan 1, 1992·Leukemia Research·G J Tricot
Jan 1, 1992·Leukemia Research·G J Mufti
Jan 1, 1991·Clinical and Laboratory Haematology·M N Narayanan, M J Lewis
Mar 1, 1991·The American Journal of Medicine·C PomeroyG A Filice
Apr 15, 1989·Cancer·J Antunez de MayoloW J Harrington
Sep 1, 1985·Cancer·N IfrahR Zittoun
Jun 1, 1993·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·J R Schriber, R S Negrin

❮ Previous
Next ❯

Citations

Jan 1, 1980·The International Journal of Biochemistry·Z J PetrykaM K Weimer
Apr 6, 2002·Clinics in Laboratory Medicine·Harold R SchumacherFermina Mazzella

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.